Skip to main content
Watch Insiders
CTNM filings

Corporate insider profile

Carmine N. Stengone Filing Activity

Latest reported as CEO and President of Contineum Therapeutics, Inc. (CTNM).

Purchase filings
0
Reported companies
1
Net open-market value
-$240,109.00
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

CTNMLatest reported

Contineum Therapeutics, Inc.

CEO and President

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Contineum Therapeutics, Inc. (CTNM)CEO and PresidentSale2,500$16.01$40,029
Jul 8, 2026Contineum Therapeutics, Inc. (CTNM)CEO and PresidentSale2,500$16.00$40,000
Jun 30, 2026Contineum Therapeutics, Inc. (CTNM)CEO and PresidentSale10,000$16.01$160,080